Legacy Pharmaceutical Packaging, LLC is recalling 3 repackaged lots of Losartan Tablets USP 50mg to the consumer level. This recall was prompted due to Torrent Pharmaceuticals LTD issuing a Voluntary Nationwide Recall of Losartan Tablets, USP, due to the detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, (API manufacturer). (US Food Recalls) More
Recalls That Should Be on Your Radar-Week of March 17 Contagionlive.com
We've compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:
Posted on 23 March 2019 | 8:01 am | Google News
Blood Pressure Medications Recalled Due To Cancer Risk LEX18 Lexington KY News
(FDA)– Legacy Pharmaceutical Packaging, LLC is recalling 43 repackaged lots of Losartan Tablets USP 25mg, 50mg, and 100mg to the consumer level.
Posted on 19 March 2019 | 4:33 am | Google News
Recon: Apple Watch Identifies Irregular Heart Beat in Large Study Regulatory Focus
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. In Focus: US. Apple Watch detects irregular heart beat in large US ...
Posted on 18 March 2019 | 2:00 am | Google News
Legacy Pharmaceutical Packaging, LLC is recalling 3 repackaged lots of Losartan Tablets USP 50mg to the consumer level. This recall was prompted due to ...
Posted on 15 March 2019 | 7:12 pm | Google News
Note: This story was updated on March 18, 2019 with the recall of 43 lots of Losartan. Dozens of medications used to treat high blood pressure have been ...
Posted on 23 January 2019 | 5:48 am | Google News